These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 20842459

  • 21. Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC).
    Wang JL, Wu DW, Cheng ZZ, Han WZ, Xu SW, Sun NN.
    Asian Pac J Cancer Prev; 2014; 15(12):4865-9. PubMed ID: 24998555
    [Abstract] [Full Text] [Related]

  • 22. CIP2A inhibits PP2A in human malignancies.
    Junttila MR, Puustinen P, Niemelä M, Ahola R, Arnold H, Böttzauw T, Ala-aho R, Nielsen C, Ivaska J, Taya Y, Lu SL, Lin S, Chan EK, Wang XJ, Grènman R, Kast J, Kallunki T, Sears R, Kähäri VM, Westermarck J.
    Cell; 2007 Jul 13; 130(1):51-62. PubMed ID: 17632056
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
    Lin TC, Lin PL, Cheng YW, Wu TC, Chou MC, Chen CY, Lee H.
    Ann Surg Oncol; 2015 Dec 13; 22 Suppl 3():S1532-9. PubMed ID: 25990966
    [Abstract] [Full Text] [Related]

  • 24. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
    Tang R, Zhong T, Dang Y, Zhang X, Li P, Chen G.
    Clin Transl Oncol; 2016 Apr 13; 18(4):360-8. PubMed ID: 26307752
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Overexpression and small molecule-triggered downregulation of CIP2A in lung cancer.
    Ma L, Wen ZS, Liu Z, Hu Z, Ma J, Chen XQ, Liu YQ, Pu JX, Xiao WL, Sun HD, Zhou GB.
    PLoS One; 2011 Apr 13; 6(5):e20159. PubMed ID: 21655278
    [Abstract] [Full Text] [Related]

  • 27. Tumor suppressor miR-375 regulates MYC expression via repression of CIP2A coding sequence through multiple miRNA-mRNA interactions.
    Jung HM, Patel RS, Phillips BL, Wang H, Cohen DM, Reinhold WC, Chang LJ, Yang LJ, Chan EK.
    Mol Biol Cell; 2013 Jun 13; 24(11):1638-48, S1-7. PubMed ID: 23552692
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Overexpression of Ang-2 mRNA in non-small cell lung cancer: association with angiogenesis and poor prognosis.
    Takanami I.
    Oncol Rep; 2004 Oct 13; 12(4):849-53. PubMed ID: 15375511
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical significance of SH2B1 adaptor protein expression in non-small cell lung cancer.
    Zhang H, Duan CJ, Chen W, Wang SQ, Zhang SK, Dong S, Cheng YD, Zhang CF.
    Asian Pac J Cancer Prev; 2012 Oct 13; 13(5):2355-62. PubMed ID: 22901222
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.